First-in-Class Prescription Digital Therapeutic Effective for Episodic Migraine – Medscape

Read article - Features comments by Stewart Tepper, a clinical professor of neurology, who served as a co-investigator in a clinical trial for a novel prescription digital therapeutic, CT-132 by Click Therapeutics, that has shown to significantly reduce monthly migraine days in individuals with episodic migraine. "It's a way of enabling people to access various state-of-the-art behavioral techniques to use alongside their existing medication to offer additional relief," said Tepper.